dimercaprol has been researched along with Chronic Lung Injury in 2 studies
Dimercaprol: An anti-gas warfare agent that is effective against Lewisite (dichloro(2-chlorovinyl)arsine) and formerly known as British Anti-Lewisite or BAL. It acts as a chelating agent and is used in the treatment of arsenic, gold, and other heavy metal poisoning.
dimercaprol : A dithiol that is propane-1,2-dithiol in which one of the methyl hydrogens is replaced by a hydroxy group. a chelating agent originally developed during World War II as an experimental antidote against the arsenic-based poison gas Lewisite, it has been used clinically since 1949 for the treatment of poisoning by arsenic, mercury and gold. It can also be used for treatment of poisoning by antimony, bismuth and possibly thallium, and (with sodium calcium edetate) in cases of acute leaad poisoning. Administration is by (painful) intramuscular injection of a suspension of dimercaprol in peanut oil, typically every 4 hours for 2-10 days depending on the toxicity. In the past, dimercaprol was also used for the treatment of Wilson's disease, a severely debilitating genetic disorder in which the body tends to retain copper, with resultant liver and brain injury.
| Excerpt | Relevance | Reference |
|---|---|---|
| "E-cigarette or vaping-use related acute lung injury (EVALI) is a spectrum of radiographic and histologic patterns consistent with acute to subacute lung injury." | 1.91 | Bronchoalveolar Lavage (BAL) and Pathologic Assessment of Electronic Cigarette or Vaping Product Use-associated Lung Injury (EVALI): The EVALI-BAL Study, A Multicenter Cohort. ( De Cardenas, J; DiBardino, D; Eissenberg, T; Giannini, H; Giovacchini, CX; Harry-Hernandez, S; Illei, PB; Kapp, CM; Los, JG; Maldonado, F; Meldrum, C; Roller, L; Shojaee, S; Thiboutot, J; Wahidi, MM; Yarmus, LB, 2023) |
| "Acute eosinophilic pneumonia (AEP) is a rare cause of respiratory failure." | 1.91 | Vaping Associated Acute Eosinophilic Pneumonia: A Clinical and Radiologic Mimicker of COVID-19. ( Bonnier, A; Chong, WH; Nida, A; Saha, BK; Saha, S, 2023) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Harry-Hernandez, S | 1 |
| Thiboutot, J | 1 |
| Wahidi, MM | 1 |
| Giovacchini, CX | 1 |
| De Cardenas, J | 1 |
| Meldrum, C | 1 |
| Los, JG | 1 |
| Illei, PB | 1 |
| Shojaee, S | 1 |
| Eissenberg, T | 1 |
| DiBardino, D | 1 |
| Giannini, H | 1 |
| Maldonado, F | 1 |
| Roller, L | 1 |
| Yarmus, LB | 1 |
| Kapp, CM | 1 |
| Bonnier, A | 1 |
| Nida, A | 1 |
| Chong, WH | 1 |
| Saha, S | 1 |
| Saha, BK | 1 |
2 other studies available for dimercaprol and Chronic Lung Injury
| Article | Year |
|---|---|
Bronchoalveolar Lavage (BAL) and Pathologic Assessment of Electronic Cigarette or Vaping Product Use-associated Lung Injury (EVALI): The EVALI-BAL Study, A Multicenter Cohort.
Topics: Adolescent; Adult; Aged; Bronchoalveolar Lavage; Dimercaprol; Electronic Nicotine Delivery Systems; | 2023 |
Vaping Associated Acute Eosinophilic Pneumonia: A Clinical and Radiologic Mimicker of COVID-19.
Topics: Adult; COVID-19; Dimercaprol; Electronic Nicotine Delivery Systems; Humans; Lung Injury; Male; Pulmo | 2023 |